Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Piramal Boosts N American Capacity With Ash Stevens Deal

Executive Summary

Cash-flush Piramal Enterprises is ramping up its North American drug manufacturing operations through the purchase of Ash Stevens, a US company making high-potency active pharmaceutical ingredients, in the latest in a string of deals for the unconventional Indian group.


Related Content

How Piramal Plans To Scale Up In Critical Care, Build On Acquisitions
India's Piramal Adds Four Pfizer Consumer Brands Pursuing Market Lead


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts